Logo image of OFIX

ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OFIX - US68752M1080 - Common Stock

15.16 USD
+0.17 (+1.13%)
Last: 12/24/2025, 7:53:33 PM
15.16 USD
0 (0%)
After Hours: 12/24/2025, 7:53:33 PM
Fundamental Rating

2

Overall OFIX gets a fundamental rating of 2 out of 10. We evaluated OFIX against 185 industry peers in the Health Care Equipment & Supplies industry. OFIX may be in some trouble as it scores bad on both profitability and health. OFIX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OFIX had negative earnings in the past year.
In the past year OFIX had a positive cash flow from operations.
In the past 5 years OFIX reported 4 times negative net income.
In multiple years OFIX reported negative operating cash flow during the last 5 years.
OFIX Yearly Net Income VS EBIT VS OCF VS FCFOFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

OFIX's Return On Assets of -14.31% is in line compared to the rest of the industry. OFIX outperforms 57.30% of its industry peers.
Looking at the Return On Equity, with a value of -26.92%, OFIX is in line with its industry, outperforming 58.38% of the companies in the same industry.
Industry RankSector Rank
ROA -14.31%
ROE -26.92%
ROIC N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
OFIX Yearly ROA, ROE, ROICOFIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

OFIX has a better Gross Margin (68.27%) than 72.97% of its industry peers.
In the last couple of years the Gross Margin of OFIX has declined.
OFIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
OFIX Yearly Profit, Operating, Gross MarginsOFIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OFIX has more shares outstanding
The number of shares outstanding for OFIX has been increased compared to 5 years ago.
Compared to 1 year ago, OFIX has a worse debt to assets ratio.
OFIX Yearly Shares OutstandingOFIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OFIX Yearly Total Debt VS Total AssetsOFIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

OFIX has an Altman-Z score of 1.28. This is a bad value and indicates that OFIX is not financially healthy and even has some risk of bankruptcy.
OFIX has a Altman-Z score (1.28) which is in line with its industry peers.
A Debt/Equity ratio of 0.39 indicates that OFIX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.39, OFIX perfoms like the industry average, outperforming 47.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACCN/A
WACC7.85%
OFIX Yearly LT Debt VS Equity VS FCFOFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.47 indicates that OFIX has no problem at all paying its short term obligations.
OFIX's Current ratio of 2.47 is in line compared to the rest of the industry. OFIX outperforms 50.27% of its industry peers.
A Quick Ratio of 1.38 indicates that OFIX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.38, OFIX is not doing good in the industry: 62.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.38
OFIX Yearly Current Assets VS Current LiabilitesOFIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OFIX have decreased strongly by -10900.00% in the last year.
Measured over the past years, OFIX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.14% on average per year.
OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.31%.
The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%

3.2 Future

OFIX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -443.00% yearly.
The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y-23152%
EPS Next 2Y-1428.2%
EPS Next 3Y-443%
EPS Next 5YN/A
Revenue Next Year2.31%
Revenue Next 2Y4.06%
Revenue Next 3Y4.76%
Revenue Next 5Y4.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OFIX Yearly Revenue VS EstimatesOFIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
OFIX Yearly EPS VS EstimatesOFIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OFIX. In the last year negative earnings were reported.
Also next year OFIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OFIX Price Earnings VS Forward Price EarningsOFIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFIX Per share dataOFIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OFIX's earnings are expected to decrease with -443.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1428.2%
EPS Next 3Y-443%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OFIX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (12/24/2025, 7:53:33 PM)

After market: 15.16 0 (0%)

15.16

+0.17 (+1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-23 2026-02-23/amc
Inst Owners91.37%
Inst Owner Change-1.84%
Ins Owners1.4%
Ins Owner Change-0.05%
Market Cap600.34M
Revenue(TTM)818.06M
Net Income(TTM)-119.12M
Analysts85.45
Price Target23.26 (53.43%)
Short Float %3.36%
Short Ratio5.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.73%
Min EPS beat(2)-37.41%
Max EPS beat(2)9.96%
EPS beat(4)3
Avg EPS beat(4)47.99%
Min EPS beat(4)-37.41%
Max EPS beat(4)139.22%
EPS beat(8)7
Avg EPS beat(8)81.32%
EPS beat(12)11
Avg EPS beat(12)87.39%
EPS beat(16)13
Avg EPS beat(16)57.92%
Revenue beat(2)2
Avg Revenue beat(2)0.97%
Min Revenue beat(2)0.8%
Max Revenue beat(2)1.14%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)-1.67%
Revenue beat(16)5
Avg Revenue beat(16)-1.56%
PT rev (1m)0.29%
PT rev (3m)1.11%
EPS NQ rev (1m)16.22%
EPS NQ rev (3m)-57.62%
EPS NY rev (1m)-1.95%
EPS NY rev (3m)13.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF 20.43
P/B 1.36
P/tB 3.49
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.74
OCFY4.89%
SpS20.66
BVpS11.17
TBVpS4.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.31%
ROE -26.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.27%
FCFM N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.23%
Cap/Sales 3.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.38
Altman-Z 1.28
F-Score5
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
EPS Next Y-23152%
EPS Next 2Y-1428.2%
EPS Next 3Y-443%
EPS Next 5YN/A
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%
Revenue Next Year2.31%
Revenue Next 2Y4.06%
Revenue Next 3Y4.76%
Revenue Next 5Y4.62%
EBIT growth 1Y-2.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.97%
EBIT Next 3Y51.04%
EBIT Next 5Y38.14%
FCF growth 1Y96.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.14%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%

ORTHOFIX MEDICAL INC / OFIX FAQ

Can you provide the ChartMill fundamental rating for ORTHOFIX MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to OFIX.


Can you provide the valuation status for ORTHOFIX MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to ORTHOFIX MEDICAL INC (OFIX). This can be considered as Overvalued.


Can you provide the profitability details for ORTHOFIX MEDICAL INC?

ORTHOFIX MEDICAL INC (OFIX) has a profitability rating of 2 / 10.


What is the earnings growth outlook for ORTHOFIX MEDICAL INC?

The Earnings per Share (EPS) of ORTHOFIX MEDICAL INC (OFIX) is expected to decline by -23152% in the next year.